General Information of This Metabolic Reaction (MR) (ID:
MR000942) |
Formula |
|
Reactant |
Escitalopram |
Product |
S-desmethylcitalopram |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Demethylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Identification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro Drug Metab Dispos. 2009 Dec;37(12):2340-8. doi: 10.1124/dmd.109.029355.
|
2 |
PharmGKB summary: citalopram pharmacokinetics pathway. Pharmacogenet Genomics. 2011 Nov;21(11):769-72.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.